These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6422 related articles for article (PubMed ID: 2978619)

  • 1. Analysis of melanoma antigen and its involvement in tumor-escape mechanisms.
    Taniguchi M; Sakatsume M; Harada Y; Nores GA; Hakomori S
    Princess Takamatsu Symp; 1988; 19():247-54. PubMed ID: 2978619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape mechanisms of melanoma from immune system by soluble melanoma antigen.
    Takahashi K; Ono K; Hirabayashi Y; Taniguchi M
    J Immunol; 1988 May; 140(9):3244-8. PubMed ID: 2452202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GM3 ganglioside as melanoma specific antigen and its biological function].
    Hirabayashi Y; Taniguchi M
    Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse melanoma antigen recognized by Lyt-2- and L3T4- cytotoxic T-lymphocytes.
    Ono K; Takahashi K; Hirabayashi Y; Itoh T; Hiraga Y; Taniguchi M
    Cancer Res; 1988 May; 48(10):2730-3. PubMed ID: 2452012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density of GM3 with normal primary structure determines mouse melanoma antigenicity; a new concept of tumor antigen.
    Harada Y; Sakatsume M; Nores GA; Hakomori S; Taniguchi M
    Jpn J Cancer Res; 1989 Oct; 80(10):988-92. PubMed ID: 2533193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
    Nores GA; Dohi T; Taniguchi M; Hakomori S
    J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.
    Harada Y; Sakatsume M; Taniguchi M
    Jpn J Cancer Res; 1990 Apr; 81(4):383-7. PubMed ID: 2142151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mouse melanoma antigen immunological properties, structure and genes].
    Taniguchi M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):826-33. PubMed ID: 2938547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
    Dohi T; Nores G; Hakomori S
    Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1596-600. PubMed ID: 16185524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.
    Gabri MR; Ripoll GV; Alonso DF; Gómez DE
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):669-77. PubMed ID: 12474053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive T-cell clones which suppress cytotoxic T cell responses.
    Sakatsume M; Harada Y; Ling X; Yasumoto A; Kurosu A; Koseki H; Saito T; Kantake M; Taniguchi M
    Int Immunol; 1991 Apr; 3(4):377-84. PubMed ID: 1831655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
    Brondz BD; Kahn ES; Chervonsky AV; Isakova VR; Apasov SG; Blandova ZK
    Exp Clin Immunogenet; 1987; 4(4):211-21. PubMed ID: 2978841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A; Gershon RK
    J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.
    Tsai V; Southwood S; Sidney J; Sakaguchi K; Kawakami Y; Appella E; Sette A; Celis E
    J Immunol; 1997 Feb; 158(4):1796-802. PubMed ID: 9029118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 322.